MBK Partners, a Seoul-based private-equity firm, launched a $1.5 billion tender offer to secure a controlling stake in nonferrous-metal producer Korea Zinc, sending the smelter’s stock to a record high
Related Posts
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
Honeywell Strikes $1.8 Billion Deal for Liquefied Natural Gas Business
Honeywell will buy the Air Products unit in its fourth acquisition in recent months as natural-gas demand grows.
Woodside Ready to Advance Driftwood LNG Selldown Talks
Woodside Energy is seeking to advance talks on the possible sale of a stake in the Driftwood LNG development in the southern U.S. in parallel […]